Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haifeng Qin

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Fitoterapia|March 14, 2026
From computational prediction to in vitro experimental validation: Identifying active compounds in longan leaves and their anti-colorectal cancer mechanismsJinrui Wei, Yuxin Xie, Jianfeng Qin, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|May 23, 2012
[Clinical observation of EGFR-TKI as a first-line therapy on advanced non-small cell lung cancer]Jianjie Li, Lili Qu, Xing Wei, et al.
Frontiers in Physiology|January 10, 2022
Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular EdemaShiyue Qin, Chaoyang Zhang, Haifeng Qin, et al.
World Journal of Surgical Oncology|September 26, 2023
Application of MFI-5 in severe complications and unfavorable outcomes after radical resection of colorectal cancerLihong Huang, Zhifa Li, Mengru Jian, et al.
Journal of Clinical Pathology|July 27, 2013
The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologiesXiaoqing Liu, Yachao Lu, Guanshan Zhu, et al.
Molecular Medicine Reports|November 21, 2019
Exploratory study on application of MALDI‑TOF‑MS to detect serum and urine peptides related to small cell lung carcinomaPanpan Lv, Zeyuan Liu, Bin Xu, et al.
Oncology Letters|March 31, 2017
CD147 promotes the proliferation, invasiveness, migration and angiogenesis of human lung carcinoma cellsShaoxing Yang, Fei Qi, Chuanhao Tang, et al.
Annals of Translational Medicine|March 26, 2019
Aprepitant for gefitinib-induced refractory pruritus in Chinese malignancy populationHaifeng Qin, Fang Wang, Ke Wang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|July 23, 2013
[How to make the choice in the retreatment of EGFR-TKI for advanced NSCLC patients who benefited from prior gefitinib therapy: the original drug or switching to a second EGFR-TKI?]Chuanhao Tang, Xiaoyan Li, Wanfeng Guo, et al.
Frontiers of Medicine|July 17, 2022
Anlotinib as third- or further-line therapy for short-term relapsed small-cell lung cancer: subgroup analysis of a randomized phase 2 study (ALTER1202)Jianhua Shi, Ying Cheng, Qiming Wang, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Fitoterapia|March 14, 2026
From computational prediction to in vitro experimental validation: Identifying active compounds in longan leaves and their anti-colorectal cancer mechanismsJinrui Wei, Yuxin Xie, Jianfeng Qin, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|May 23, 2012
[Clinical observation of EGFR-TKI as a first-line therapy on advanced non-small cell lung cancer]Jianjie Li, Lili Qu, Xing Wei, et al.
Frontiers in Physiology|January 10, 2022
Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular EdemaShiyue Qin, Chaoyang Zhang, Haifeng Qin, et al.
World Journal of Surgical Oncology|September 26, 2023
Application of MFI-5 in severe complications and unfavorable outcomes after radical resection of colorectal cancerLihong Huang, Zhifa Li, Mengru Jian, et al.
Journal of Clinical Pathology|July 27, 2013
The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologiesXiaoqing Liu, Yachao Lu, Guanshan Zhu, et al.
Molecular Medicine Reports|November 21, 2019
Exploratory study on application of MALDI‑TOF‑MS to detect serum and urine peptides related to small cell lung carcinomaPanpan Lv, Zeyuan Liu, Bin Xu, et al.
Oncology Letters|March 31, 2017
CD147 promotes the proliferation, invasiveness, migration and angiogenesis of human lung carcinoma cellsShaoxing Yang, Fei Qi, Chuanhao Tang, et al.
Annals of Translational Medicine|March 26, 2019
Aprepitant for gefitinib-induced refractory pruritus in Chinese malignancy populationHaifeng Qin, Fang Wang, Ke Wang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|July 23, 2013
[How to make the choice in the retreatment of EGFR-TKI for advanced NSCLC patients who benefited from prior gefitinib therapy: the original drug or switching to a second EGFR-TKI?]Chuanhao Tang, Xiaoyan Li, Wanfeng Guo, et al.
Frontiers of Medicine|July 17, 2022
Anlotinib as third- or further-line therapy for short-term relapsed small-cell lung cancer: subgroup analysis of a randomized phase 2 study (ALTER1202)Jianhua Shi, Ying Cheng, Qiming Wang, et al.
Pageof 8